Orchid's founders eye raising holding as Symphony, Solarex exit
This article was originally published in Scrip
Executive Summary
The founders of India's Orchid Chemicals & Pharmaceuticals, which has seen the exit of certain high profile investors over the recent past, are planning to further consolidate their holding in the company over the next few years.